{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:22:35Z","timestamp":1787725355958,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.drugalcdep.2020.107988","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T21:07:09Z","timestamp":1587762429000},"page":"107988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats"],"prefix":"10.1016","volume":"212","author":[{"given":"Cassie M.","family":"Chandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Bardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.107988_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2014.02.032","article-title":"Relationship between ethanol-induced activity and anxiolysis in the open field, elevated plus maze, light-dark box, and ethanol intake in adolescent rats","volume":"265","author":"Acevedo","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4062\/biomolther.2014.056","article-title":"Conditioned place preference and self-administration induced by nicotine in adolescent and adult rats","volume":"22","author":"Ahsan","year":"2014","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/acer.13601","article-title":"Nicotine-Use\/Smoking is associated with the efficacy of naltrexone in the treatment of alcohol dependence","volume":"42","author":"Anton","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2009.05.025","article-title":"Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients","volume":"105","author":"Baltieri","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00210-010-0498-5","article-title":"Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats","volume":"381","author":"Biala","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-3057(97)00598-4","article-title":"Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats","volume":"60","author":"Biggs","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0035","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/acer.13994","article-title":"Longitudinal findings from a randomized clinical trial of varenicline for alcohol use disorder with comorbid cigarette smoking","volume":"43","author":"Bold","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02196920","article-title":"Psychiatric comorbidity of smoking and nicotine dependence","volume":"25","author":"Breslau","year":"1995","journal-title":"Behav. Genet."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0045","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0050","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00213-018-5163-6","article-title":"alpha5GABAA subunit-containing receptors and sweetened alcohol cue-induced reinstatement and active sweetened alcohol self-administration in male rats","volume":"236","author":"Chandler","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugalcdep.2014.05.019","article-title":"Predictors of quit attempts and successful quit attempts among individuals with alcohol use disorders in a nationally representative sample","volume":"141","author":"Chiappetta","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00008877-199712000-00008","article-title":"Effect of naltrexone and its derivatives, nalmefene and naltrindole, on conditioned anticipatory behaviour and saccharin intake in rats","volume":"8","author":"Chow","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lfs.2005.12.045","article-title":"Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia","volume":"79","author":"Chuck","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00589894","article-title":"Nicotine maintains robust self-administration in rats on a limited-access schedule","volume":"99","author":"Corrigall","year":"1989","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0075","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1177\/1060028014545806","article-title":"Varenicline in the treatment of alcohol use disorders","volume":"48","author":"Erwin","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0080","first-page":"162","article-title":"An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"29","author":"Falk","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0085","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.299.17.2083","article-title":"A clinical blueprint to accelerate the elimination of tobacco use","volume":"299","author":"Fiore","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0090","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/acer.12513","article-title":"Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking","volume":"38","author":"Fridberg","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2015.09.009","article-title":"Effects of varenicline on operant self-administration of alcohol and\/or nicotine in a rat model of co-abuse","volume":"296","author":"Funk","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/add.12557","article-title":"Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence","volume":"109","author":"Garbutt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0105","first-page":"208","article-title":"Smoking cessation and alcohol abstinence: what do the data tell us?","volume":"29","author":"Gulliver","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnsys.2019.00035","article-title":"Corticostriatal oscillations predict high vs. low drinkers in a rat model of limited access alcohol consumption","volume":"13","author":"Henricks","year":"2019","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.mcna.2018.02.008","article-title":"Pharmacotherapy for alcohol use disorder","volume":"102","author":"Holt","year":"2018","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0120","first-page":"171","article-title":"Clinical implications of the association between smoking and alcoholism. Alcohol and tobacco: from basic science to clinical practice","volume":"30","author":"Hughes","year":"1996","journal-title":"NIAAA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2017.11.017","article-title":"Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: a randomized controlled trial","volume":"184","author":"Hurt","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/acer.13396","article-title":"A double-blind randomized placebo-controlled trial of oral naltrexone for heavy-drinking smokers seeking smoking cessation treatment","volume":"41","author":"Kahler","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1601-183X.2008.00444.x","article-title":"The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation","volume":"8","author":"Kamens","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/acer.12233","article-title":"The effects of varenicline on alcohol seeking and self-administration in baboons","volume":"38","author":"Kaminski","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.alcohol.2015.10.003","article-title":"Dose-dependent effects of alcohol administration on behavioral profiles in the MCSF test","volume":"50","author":"Karlsson","year":"2016","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2018.11.017","article-title":"Smoking cessation in the context of recovery from drug and alcohol problems: prevalence, predictors, and cohort effects in a national U.S. sample","volume":"195","author":"Kelly","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0155","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/add.12261","article-title":"Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial","volume":"108","author":"King","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0165","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1523\/JNEUROSCI.4895-05.2006","article-title":"Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake","volume":"26","author":"Le","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0170","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1007\/s00213-014-3541-2","article-title":"Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse","volume":"231","author":"L\u00ea","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-005-0280-4","article-title":"Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration","volume":"184","author":"Lecca","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addbeh.2017.11.006","article-title":"Tobacco and alcohol use disorders: evaluating multimorbidity","volume":"78","author":"MacLean","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0185","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00213-018-4853-4","article-title":"Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats","volume":"235","author":"Maggio","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2018.09.008","article-title":"An improved model of ethanol and nicotine co-use in female P rats: effects of naltrexone, varenicline, and the selective nicotinic alpha6beta2* antagonist r-bPiDI","volume":"193","author":"Maggio","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0195","article-title":"Behavioral economic approach to understanding co-use of alcohol and nicotine in female P rats","author":"Maggio","year":"2018","journal-title":"Research Society on Alcoholism, San Diego CA."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0200","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1530-0277.2006.00098.x","article-title":"Limited-access consumption of ascending ethanol concentrations in alcohol-preferring, nonpreferring, and Sprague-Dawley rats","volume":"30","author":"Martinetti","year":"2006","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.alcohol.2013.09.044","article-title":"The alcohol-preferring (P) and high-alcohol-drinking (HAD) rats--animal models of alcoholism","volume":"48","author":"McBride","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s002130100747","article-title":"Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism","volume":"156","author":"Miller","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0225","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fnins.2015.00424","article-title":"Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats","volume":"9","author":"Momeni","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0230","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drugalcdep.2016.10.018","article-title":"Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: a systematic review on varenicline","volume":"169","author":"Motschman","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pbb.2018.02.003","article-title":"Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats","volume":"167","author":"Nieto","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0240","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-009-1739-5","article-title":"The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats","volume":"208","author":"O\u2019Connor","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0245","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S146114570800936X","article-title":"Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation","volume":"12","author":"O\u2019Malley","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","article-title":"Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: a randomized clinical trial","volume":"75","author":"O\u2019Malley","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0255","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ntr\/ntx105","article-title":"Changes in alcohol consumption during a stop-smoking attempt and differences between smokers using nicotine replacement and smokers using varenicline","volume":"20","author":"Przulj","year":"2018","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.drugalcdep.2019.07.001","article-title":"Smoking relapse risk is increased among individuals in recovery","volume":"202","author":"Quisenberry","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0265","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.bjp.0707612","article-title":"Region-specific effects of N,N\u2019-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo","volume":"153","author":"Rahman","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0270","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s00213-016-4354-2","article-title":"The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats","volume":"233","author":"Randall","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2017.03.005","article-title":"Sex differences in alcohol self-administration and relapse-like behavior in Long-Evans rats","volume":"156","author":"Randall","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/alcalc\/agq020","article-title":"Persistent high alcohol consumption in alcohol-preferring (P) rats results from a lack of normal aversion to alcohol","volume":"45","author":"Rezvani","year":"2010","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0285","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2015.09.002","article-title":"Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats","volume":"156","author":"Scuppa","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0295","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/npp.2010.15","article-title":"Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading","volume":"35","author":"Simms","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0300","article-title":"Naltrexone: a history and future directions","volume":"2018","author":"Srivastava","year":"2018","journal-title":"Cerebrum"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0305","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0310","first-page":"110","article-title":"Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes","volume":"114","author":"Tsoh","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbr.2015.06.013","article-title":"Ethanol consumption in the Sprague-Dawley rat increases sensitivity of the dorsal raphe nucleus to 5,7-dihydroxytryptamine","volume":"295","author":"Vasudeva","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0320","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0024-3205(86)90601-6","article-title":"Naltrexone blocks the post-shock increase of ethanol consumption","volume":"38","author":"Volpicelli","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0325","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0330","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00213-019-5174-y","article-title":"Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats","volume":"236","author":"Waeiss","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0335","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/acer.12840","article-title":"Cigarette smoking and risk of alcohol use relapse among adults in recovery from alcohol use disorders","volume":"39","author":"Weinberger","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.107988_bib0340","first-page":"381","article-title":"Concurrent inpatient smoking cessation and alcohol abstinence programs for alcoholics and their outcomes","volume":"49","author":"Yokoyama","year":"2014","journal-title":"Nihon Arukoru Yakubutsu Igakkai Zasshi"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620301538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:02:42Z","timestamp":1759827762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620301538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":68,"alternative-id":["S0376871620301538"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107988","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107988"}}